COCCCN1CC(=O)N2C(c3ccc(OC)c(OC)c3)c3[nH]c4ccccc4c3C[C@H]2C1=O
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?